ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AKBA Akebia Therapeutics Inc

1.04
-0.01 (-0.95%)
Last Updated: 14:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Akebia Therapeutics Inc NASDAQ:AKBA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.01 -0.95% 1.04 1.04 1.05 1.04 1.04 1.04 8,513 14:30:00

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference

14/05/2024 1:00pm

PR Newswire (US)


Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more Akebia Therapeutics Charts.

CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the 2nd Annual HCW Bioconnect Investor Conference on Monday, May 20th, 2024 at 3:00 p.m. ET.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease (PRNewsfoto/Akebia Therapeutics, Inc.)

The 2nd Annual HCW Bioconnect Investor Conference will take place in New York, NY on May 20, 2024.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-2nd-annual-hcw-bioconnect-investor-conference-302144820.html

SOURCE Akebia Therapeutics, Inc.

Copyright 2024 PR Newswire

1 Year Akebia Therapeutics Chart

1 Year Akebia Therapeutics Chart

1 Month Akebia Therapeutics Chart

1 Month Akebia Therapeutics Chart